PRECIGEN INC (PGEN) Fundamental Analysis & Valuation

NASDAQ:PGEN • US74017N1054

Current stock price

3.98 USD
+0.03 (+0.76%)
At close:
3.9702 USD
-0.01 (-0.25%)
After Hours:

This PGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PGEN Profitability Analysis

1.1 Basic Checks

  • PGEN had negative earnings in the past year.
  • PGEN had a negative operating cash flow in the past year.
  • In the past 5 years PGEN reported 4 times negative net income.
  • PGEN had a negative operating cash flow in each of the past 5 years.
PGEN Yearly Net Income VS EBIT VS OCF VS FCFPGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M -500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -276.29%, PGEN is doing worse than 91.68% of the companies in the same industry.
  • PGEN's Return On Equity of -2054.62% is on the low side compared to the rest of the industry. PGEN is outperformed by 82.98% of its industry peers.
Industry RankSector Rank
ROA -276.29%
ROE -2054.62%
ROIC N/A
ROA(3y)-142.23%
ROA(5y)-87.84%
ROE(3y)-774.91%
ROE(5y)-477.65%
ROIC(3y)N/A
ROIC(5y)N/A
PGEN Yearly ROA, ROE, ROICPGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

  • PGEN has a better Gross Margin (50.20%) than 74.66% of its industry peers.
  • In the last couple of years the Gross Margin of PGEN has grown nicely.
  • The Profit Margin and Operating Margin are not available for PGEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y1.66%
PGEN Yearly Profit, Operating, Gross MarginsPGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PGEN Health Analysis

2.1 Basic Checks

  • PGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PGEN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PGEN has more shares outstanding
  • PGEN has a worse debt/assets ratio than last year.
PGEN Yearly Shares OutstandingPGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
PGEN Yearly Total Debt VS Total AssetsPGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • PGEN has an Altman-Z score of -16.40. This is a bad value and indicates that PGEN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -16.40, PGEN is doing worse than 81.24% of the companies in the same industry.
  • PGEN has a Debt/Equity ratio of 4.46. This is a high value indicating a heavy dependency on external financing.
  • PGEN's Debt to Equity ratio of 4.46 is on the low side compared to the rest of the industry. PGEN is outperformed by 80.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.46
Debt/FCF N/A
Altman-Z -16.4
ROIC/WACCN/A
WACC9.15%
PGEN Yearly LT Debt VS Equity VS FCFPGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • PGEN has a Current Ratio of 3.09. This indicates that PGEN is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PGEN (3.09) is worse than 62.09% of its industry peers.
  • PGEN has a Quick Ratio of 2.83. This indicates that PGEN is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.83, PGEN is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 2.83
PGEN Yearly Current Assets VS Current LiabilitesPGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. PGEN Growth Analysis

3.1 Past

  • The earnings per share for PGEN have decreased strongly by -268.57% in the last year.
  • The Revenue has grown by 146.73% in the past year. This is a very strong growth!
  • The Revenue for PGEN have been decreasing by -37.70% on average. This is quite bad
EPS 1Y (TTM)-268.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)146.73%
Revenue growth 3Y-28.86%
Revenue growth 5Y-37.7%
Sales Q2Q%283.61%

3.2 Future

  • Based on estimates for the next years, PGEN will show a very strong growth in Earnings Per Share. The EPS will grow by 21.29% on average per year.
  • PGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 103.93% yearly.
EPS Next Y96.31%
EPS Next 2Y45.56%
EPS Next 3Y32.91%
EPS Next 5Y21.29%
Revenue Next Year577.54%
Revenue Next 2Y250.24%
Revenue Next 3Y165.76%
Revenue Next 5Y103.93%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PGEN Yearly Revenue VS EstimatesPGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
PGEN Yearly EPS VS EstimatesPGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. PGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PGEN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PGEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PGEN Price Earnings VS Forward Price EarningsPGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PGEN Per share dataPGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PGEN's earnings are expected to grow with 32.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.56%
EPS Next 3Y32.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PGEN Dividend Analysis

5.1 Amount

  • No dividends for PGEN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PGEN Fundamentals: All Metrics, Ratios and Statistics

PRECIGEN INC

NASDAQ:PGEN (4/17/2026, 8:00:00 PM)

After market: 3.9702 -0.01 (-0.25%)

3.98

+0.03 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners73.14%
Inst Owner Change0.07%
Ins Owners2.98%
Ins Owner Change2.64%
Market Cap1.41B
Revenue(TTM)9.68M
Net Income(TTM)-429.64M
Analysts80
Price Target9.69 (143.47%)
Short Float %13.02%
Short Ratio8.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-488.13%
Min EPS beat(2)-993.91%
Max EPS beat(2)17.64%
EPS beat(4)2
Avg EPS beat(4)-242.2%
Min EPS beat(4)-993.91%
Max EPS beat(4)17.64%
EPS beat(8)2
Avg EPS beat(8)-124.58%
EPS beat(12)3
Avg EPS beat(12)-87.29%
EPS beat(16)5
Avg EPS beat(16)-83.4%
Revenue beat(2)1
Avg Revenue beat(2)213.48%
Min Revenue beat(2)-45.98%
Max Revenue beat(2)472.94%
Revenue beat(4)3
Avg Revenue beat(4)153.95%
Min Revenue beat(4)-45.98%
Max Revenue beat(4)472.94%
Revenue beat(8)3
Avg Revenue beat(8)62.8%
Revenue beat(12)3
Avg Revenue beat(12)33.54%
Revenue beat(16)3
Avg Revenue beat(16)6.97%
PT rev (1m)11.76%
PT rev (3m)11.76%
EPS NQ rev (1m)57.33%
EPS NQ rev (3m)57.33%
EPS NY rev (1m)74.07%
EPS NY rev (3m)73.58%
Revenue NQ rev (1m)-13.33%
Revenue NQ rev (3m)-13.33%
Revenue NY rev (1m)17.13%
Revenue NY rev (3m)17.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 145.46
P/FCF N/A
P/OCF N/A
P/B 67.36
P/tB 564.13
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.03
BVpS0.06
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -276.29%
ROE -2054.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.2%
FCFM N/A
ROA(3y)-142.23%
ROA(5y)-87.84%
ROE(3y)-774.91%
ROE(5y)-477.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y1.66%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.36%
Cap/Sales 20.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 2.83
Altman-Z -16.4
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)91.69%
Cap/Depr(5y)74.69%
Cap/Sales(3y)87.99%
Cap/Sales(5y)66.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-268.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y96.31%
EPS Next 2Y45.56%
EPS Next 3Y32.91%
EPS Next 5Y21.29%
Revenue 1Y (TTM)146.73%
Revenue growth 3Y-28.86%
Revenue growth 5Y-37.7%
Sales Q2Q%283.61%
Revenue Next Year577.54%
Revenue Next 2Y250.24%
Revenue Next 3Y165.76%
Revenue Next 5Y103.93%
EBIT growth 1Y-12.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.84%
OCF growth 3YN/A
OCF growth 5YN/A

PRECIGEN INC / PGEN Fundamental Analysis FAQ

What is the fundamental rating for PGEN stock?

ChartMill assigns a fundamental rating of 2 / 10 to PGEN.


Can you provide the valuation status for PRECIGEN INC?

ChartMill assigns a valuation rating of 1 / 10 to PRECIGEN INC (PGEN). This can be considered as Overvalued.


How profitable is PRECIGEN INC (PGEN) stock?

PRECIGEN INC (PGEN) has a profitability rating of 1 / 10.